Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Genetic screening for synthetic lethal partners of polynucleotide kinase/phosphatase: potential for targeting SHP-1-depleted cancers.

Mereniuk TR, Maranchuk RA, Schindler A, Penner-Chea J, Freschauf GK, Hegazy S, Lai R, Foley E, Weinfeld M.

Cancer Res. 2012 Nov 15;72(22):5934-44. doi: 10.1158/0008-5472.CAN-12-0939. Epub 2012 Sep 7.

2.

Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repair.

Weinfeld M, Mani RS, Abdou I, Aceytuno RD, Glover JN.

Trends Biochem Sci. 2011 May;36(5):262-71. doi: 10.1016/j.tibs.2011.01.006. Epub 2011 Feb 25. Review.

3.

Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.

Dumitrache LC, McKinnon PJ.

Mech Ageing Dev. 2017 Jan;161(Pt A):121-129. doi: 10.1016/j.mad.2016.04.009. Epub 2016 Apr 26. Review.

4.

The function of the protein tyrosine phosphatase SHP-1 in cancer.

Wu C, Sun M, Liu L, Zhou GW.

Gene. 2003 Mar 13;306:1-12. Review.

PMID:
12657462
5.

Neurological disorders associated with DNA strand-break processing enzymes.

Jiang B, Glover JN, Weinfeld M.

Mech Ageing Dev. 2017 Jan;161(Pt A):130-140. doi: 10.1016/j.mad.2016.07.009. Epub 2016 Jul 25. Review.

Supplemental Content

Support Center